Weβre thrilled to announce that our latest research paper, ππ£π°ππͺπ΄π©πͺπ―π¨ ππ¦π΅π³π°-ππ³π’π―π΄π₯πΆπ€π΅πͺπ°π― π°π§ ππ³π°π₯πΆπ€π¦π³ ππ¦πππ΄ πͺπ― ππ¦π―π΅πͺπ·πͺπ³π’π ππ¦π€π΅π°π³ ππ’π―πΆπ§π’π€π΅πΆπ³πͺπ―π¨, has been published in the journal Viruses..
In this paper, we address strategies to suppress the phenomenon of retro-transduction, a factor that decreases production efficiency in our lentiviral vector development and manufacturing processes.
Congratulations to all the authors, especially to the first co-authors Soledad BaΓ±os-Mateos and Carlos LΓ³pez.
As Marie Fertin, our Chief Technological Innovation Officer and the leader of the work shared with all of us, βthis publication is a recognition by our peers of the high scientific and innovative value of our work and contributes to the positioning of VIVEbiotech as a world-class CDMOβ.
You can read the full article here: https://www.mdpi.com/1999-4915/16/8/1216
A huge thank you to everyone involved in this project.